nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefamandole—SLC22A11—Methotrexate—psoriatic arthritis	0.34	0.34	CbGbCtD
Cefamandole—SLC22A7—Methotrexate—psoriatic arthritis	0.324	0.324	CbGbCtD
Cefamandole—SLC22A8—Methotrexate—psoriatic arthritis	0.198	0.198	CbGbCtD
Cefamandole—SLC22A6—Methotrexate—psoriatic arthritis	0.138	0.138	CbGbCtD
